Form 4 for ETON Eton Pharmaceuticals, Inc.

Accepted 2025-06-16 00:00:00 ET · period of report 2025-06-12 · accession 0001437749-25-020518 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
M	2025-06-16	2025-06-12+	ETON	Krempa David	Chief Business Off	S - Sale	$14.83	-34.0K	622.9K	-5%	-$504.3K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2025-06-16	S	D	10,223	$14.73	612,646	D	—	—	(F3) The shares were sold in multiple trades at prices ranging from $14.50 to $14.79. The price reported above reflects the weighted average sales price. (F4) The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
2	Common	Common Stock	2025-06-12	S	D	16,977	$14.92	629,669	D	—	—	(F4) The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. (F1) The shares were sold in multiple trades at prices ranging from $14.77 to $14.98. The price reported above reflects the weighted average sales price.
3	Common	Common Stock	2025-06-13	S	D	6,800	$14.77	622,869	D	—	—	(F4) The Reporting Person will provide upon request by the Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. (F2) The shares were sold in multiple trades at prices ranging from $14.75 to $14.81. The price reported above reflects the weighted average sales price.